Cliff Asness’s INVA Holdings & Trades

First Buy
Q1 2016
Duration Held
39 Quarters
Largest Add
Q2 2017
+215,715 Shares
Current Position
302,472 Shares
$5.52 M Value

Cliff Asness's INVA Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 302,472 shares of Innoviva, Inc. (INVA) worth $5.52 M, representing 0.00% of the portfolio. First purchased in 2016-Q1, this long-term strategic position has been held for 39 quarters.

Based on 13F filings, Cliff Asness has maintained a strategic position in INVA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2017, adding 171,047 shares. Largest reduction occurred in Q2 2023, reducing 175,244 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Innoviva (INVA) Holding Value Over Time

Track share changes against reported price movement

Quarterly Innoviva (INVA) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2016 +34,645 New Buy 34,645 $12.58
Q2 2016 +22,750 Add 65.67% 57,395 $10.52
Q3 2016 -12,727 Reduce 22.17% 44,668 $10.99
Q4 2016 -44,668 Sold Out 44,668 $10.99
Q2 2017 +215,715 New Buy 215,715 $12.80
Q3 2017 +62,846 Add 29.13% 278,561 $14.12
Q4 2017 +62,175 Add 22.32% 340,736 $14.19
Q1 2018 -21,810 Reduce 6.40% 318,926 $16.67
Q2 2018 -84,157 Reduce 26.39% 234,769 $13.80
Q3 2018 -113,794 Reduce 48.47% 120,975 $15.24
Q4 2018 -113 Reduce 0.09% 120,862 $17.45
Q1 2019 +51,544 Add 42.65% 172,406 $14.03
Q2 2019 -28,359 Reduce 16.45% 144,047 $14.56
Q3 2019 +99,171 Add 68.85% 243,218 $10.54
Q4 2019 -2,522 Reduce 1.04% 240,696 $14.16
Q1 2020 -10,780 Reduce 4.48% 229,916 $11.76
Q2 2020 -12,186 Reduce 5.30% 217,730 $13.98
Q3 2020 -39,266 Reduce 18.03% 178,464 $10.45
Q4 2020 +11,147 Add 6.25% 189,611 $12.39
Q1 2021 -55,383 Reduce 29.21% 134,228 $11.95
Q2 2021 -12,559 Reduce 9.36% 121,669 $13.41
Q3 2021 -4,268 Reduce 3.51% 117,401 $16.71
Q4 2021 +12,767 Add 10.87% 130,168 $17.25
Q1 2022 +902 Add 0.69% 131,070 $19.35
Q2 2022 +20,359 Add 15.53% 151,429 $14.76
Q3 2022 +144,782 Add 95.61% 296,211 $11.61
Q4 2022 +106,260 Add 35.87% 402,471 $13.25
Q1 2023 +131,219 Add 32.60% 533,690 $11.25
Q2 2023 -175,244 Reduce 32.84% 358,446 $12.73
Q3 2023 -49,221 Reduce 13.73% 309,225 $12.99
Q4 2023 -109,875 Reduce 35.53% 199,350 $16.04
Q1 2024 -23,597 Reduce 11.84% 175,753 $15.24
Q2 2024 -444 Reduce 0.25% 175,309 $16.40
Q3 2024 -18,735 Reduce 10.69% 156,574 $19.31
Q4 2024 -14,435 Reduce 9.22% 142,139 $17.35
Q1 2025 +25,317 Add 17.81% 167,456 $18.13
Q2 2025 +29,299 Add 17.50% 196,755 $20.09
Q3 2025 +105,717 Add 53.73% 302,472 $18.25

Cliff Asness's Innoviva Investment FAQs

Cliff Asness first purchased Innoviva, Inc. (INVA) in Q1 2016, acquiring 34,645 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Innoviva, Inc. (INVA) for 39 quarters since Q1 2016.

Cliff Asness's largest addition to Innoviva, Inc. (INVA) was in Q2 2017, adding 215,715 shares worth $2.76 M.

According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 302,472 shares of Innoviva, Inc. (INVA), valued at approximately $5.52 M.

As of the Q3 2025 filing, Innoviva, Inc. (INVA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in Innoviva, Inc. (INVA) was 533,690 shares, as reported at the end of Q1 2023.